Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies
Authors:
- Tamara Čimbora-ZovkoTČTamara Čimbora-Zovko
- Sanja TomićSTSanja Tomić
- Tihana JelušićTJTihana Jelušić
- Marijan KočevarMKMarijan Kočevar
- Slovenko PolancSPSlovenko Polanc
- Maja OsmakMOMaja Osmak
- 1 April 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (7) , 2375-2387
Abstract
No abstract availableKeywords
Funding Information
- The Ministry of Higher Education, Science and Technology of Slovenia
- Slovenian Research Agency
- Ministry of Science, Education and Sport of the Republic of Croatia
This publication has 44 references indexed in Scilit:
- Discovery of new Gram-negative antivirulence drugs: Structure and properties of novel E. coli WaaC inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- New Series of Antiprion Compounds: Pyrazolone Derivatives Have the Potent Activity of Inhibiting Protease-Resistant Prion Protein AccumulationJournal of Medicinal Chemistry, 2007
- Copper‐Promoted Cycloaddition of Diazocarbonyl Compounds and AcetylidesAngewandte Chemie International Edition, 2007
- Pyrazol-3-ones. Part III: Reactivity of the Ring SubstituentsAdvances in Heterocyclic Chemistry, 2007
- Vascular disrupting agentsBioorganic & Medicinal Chemistry, 2007
- Effects of α-substitutions on structure and biological activity of anticancer chalconesBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and biological activity of N,N-dialkylaminoalkyl-substituted bisindolyl and diphenyl pyrazolone derivativesBioorganic & Medicinal Chemistry, 2006
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- Pyrazol-3-ones. Part II: Reactions of the Ring AtomsAdvances in Heterocyclic Chemistry, 2004
- Pyrazol-3-ones part 1: Synthesis and applications2001